MCS-8

N/A

Report date: 2024/07/27 20:00:03

Base Information

Drug NameMCS-8
Drug Alias NameMCS® MCS-8MCS-8
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesHealth Ever Bio-Tech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHealth Ever Bio-Tech Co Ltd
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A